ALX Oncology Holdings Inc.ALXONASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank43
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P43
Within normal range
Average
-588.66%
Historical baseline
PeriodValueYoY Change
20250.00%-
20240.00%-
20230.00%-
20220.00%-
20210.00%+100.0%
2020-3676.90%-840.1%
2019-391.14%+39.0%
2018-641.27%-